On October 19, 2013, Mr. Ye Shengqin, President of Longyao Biology, visited Cytori Therapeutics, a NASDAQ-listed stem cell company located in San Diego, California, and made a detailed inspection of Cytori's technical details.
On March 19, 2014, David Oxley, Global Vice President of Cytori, visited Shanghai Longyao and reached a preliminary intention for cooperation in China.